Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.

Published in:

British Journal of Haematology, 2020, v. 189, n. 1, p. 84, doi. 10.1111/bjh.16300

By:

• Thieblemont, Catherine;
• Howlett, Susannah;
• Casasnovas, René‐Olivier;
• Mounier, Nicolas;
• Perrot, Aurore;
• Morschhauser, Franck;
• Fruchart, Christophe;
• Daguindau, Nicolas;
• Eygen, Koen;
• Obéric, Lucie;
• Bouabdallah, Reda;
• Pica, Gian Matteo;
• Nicolas‐Virezelier, Emmanuelle;
• Abraham, Julie;
• Fitoussi, Olivier;
• Snauwaert, Sylvia;
• Eisenmann, Jean‐Claude;
• Lionne‐Huyghe, Pauline;
• Bron, Dominique;
• Tricot, Sabine

Publication type:

Article